A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Clinical trial NCT07089992 · RECRUITING
Trial details
- NCT number
- NCT07089992
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-04
- Primary completion
- 2028-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.